4//SEC Filing
Sevion Therapeutics, Inc. 4
Accession 0001144204-14-070159
CIK 0001035354operating
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 5:03 PM ET
Size
8.0 KB
Accession
0001144204-14-070159
Insider Transaction Report
Form 4
FORBES CHRISTOPHER
Director10% Owner
Transactions
- Award
Common Stock Option (right to buy)
2014-11-18+27,882→ 64,107 totalExercise: $0.83From: 2014-11-18Exp: 2024-11-18→ Common Stock (27,882 underlying) - Award
Common Stock Option (right to buy)
2014-11-18$0.42/sh+3,462$1,454→ 67,569 totalExercise: $0.83From: 2014-11-18Exp: 2024-11-18→ Common Stock (3,462 underlying)
Footnotes (3)
- [F1]50% of such options vest on the date of grant and 50% of such options will vest on the first anniversary of the date of grant.
- [F2]Such options were granted in lieu of cash compensation under the Company's independent director compensation plan and are immediately exercisable.
- [F3]Such option grant was approved by the Company's compensation committee in September 2014 and, consistent with prior practice, was granted on the second business day following the Company's filing of its quarterly report on Form 10-Q for the period ending September 30, 2014.
Documents
Issuer
Sevion Therapeutics, Inc.
CIK 0001035354
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001035354
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 5:03 PM ET
- Size
- 8.0 KB